Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.

Tobacco smoking is the most important and well-established bladder cancer risk factor and a rich source of chemical carcinogens and reactive oxygen species that can induce damage to DNA in urothelial cells. Therefore, common variation in DNA repair genes might modify bladder cancer risk. In this stu...

Bibliografski detalji
Glavni autori:	Stern, M, Lin, J, Figueroa, J, Kelsey, K, Kiltie, A, Yuan, J, Matullo, G, Fletcher, T, Benhamou, S, Taylor, J, Placidi, D, Zhang, Z, Steineck, G, Rothman, N, Kogevinas, M, Silverman, D, Malats, N, Chanock, S, Wu, X, Karagas, MR, Andrew, A, Nelson, H, Bishop, D, Sak, S, Choudhury, A
Format:	Journal article
Jezik:	English
Izdano:	2009

Slični predmeti

Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk.
od: Sak, S, i dr.
Izdano: (2006)

DNA repair gene XRCC1 polymorphisms and bladder cancer risk
od: Sak, S, i dr.
Izdano: (2007)

Utility of bladder-sparing therapy vs radical cystectomy for muscle-invasive bladder cancer
od: Efstathiou, J, i dr.
Izdano: (2018)

Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer.
od: Silvia Pineda, i dr.
Izdano: (2015-12-01)

Analysis of variants in DNA damage signalling genes in bladder cancer
od: Choudhury, A, i dr.
Izdano: (2008)

DNA repair gene XPC polymorphisms, smoking, occupational exposures and the risk of bladder transitional cell carcinoma
od: Sak, S, i dr.
Izdano: (2005)

DNA repair gene <it>XRCC1 </it>polymorphisms and bladder cancer risk
od: Bishop D Timothy, i dr.
Izdano: (2007-04-01)

The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder.
od: Sak, S, i dr.
Izdano: (2005)

Genome-wide CNV analysis replicates the association between <it>GSTM1</it> deletion and bladder cancer: a support for using continuous measurement from SNP-array data
od: Marenne Gaëlle, i dr.
Izdano: (2012-07-01)

Common predisposition alleles for moderately common cancers: bladder cancer.
od: Kiltie, A
Izdano: (2010)

Gemcitabine as a Chemoradiosensitiser in Bladder Cancer
od: Kerr, M, i dr.
Izdano: (2012)

Molecular epidemiology of DNA repair genes in bladder cancer.
od: Kiltie, A
Izdano: (2009)

Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk.
od: Montserrat García-Closas, i dr.
Izdano: (2007-02-01)

Analysis of variants in DNA damage signalling genes in bladder cancer
od: Bishop D Timothy, i dr.
Izdano: (2008-07-01)

Nomogram predicting bladder cancer specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: Results of an international consortium
od: M. Marchioni, i dr.
Izdano: (2020-07-01)

Genome-wide interaction study of smoking and bladder cancer risk.
od: Figueroa, J, i dr.
Izdano: (2014)

Nomogram predicting bladder cancer specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: results of an international consortium
od: C. Mir, i dr.
Izdano: (2020-10-01)

APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer.
od: Sak, S, i dr.
Izdano: (2005)

Predictive Biomarkers for Gemcitabine as a Chemoradiosensitizer in Bladder Cancer
od: Kerr, M, i dr.
Izdano: (2012)

Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis.
od: Silvia Pineda, i dr.
Izdano: (2014-01-01)

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
od: Rothman, N, i dr.
Izdano: (2010)

In vitro functional effects of XPC gene rare variants from bladder cancer patients.
od: Qiao, B, i dr.
Izdano: (2011)

RAD51: A DNA repair target for increasing the therapeutic potential in bladder cancer
od: Choudhury, A, i dr.
Izdano: (2005)

Using gene polymorphisms to assess bladder cancer risk: progress and challenges.
od: Kiltie, A
Izdano: (2012)

Using gene polymorphisms to assess bladder cancer risk: Progress and challenges
od: Kiltie, A
Izdano: (2012)

MRE11 variants as predictive markers of radiotherapy response in muscle invasive bladder cancer
od: Teo, M, i dr.
Izdano: (2012)

Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes
od: Stella Koutros, i dr.
Izdano: (2020-02-01)

Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study
od: Heaney John, i dr.
Izdano: (2007-08-01)

Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients.
od: Qiao, B, i dr.
Izdano: (2011)

Prototol for the Prospective Sample Collection for Cancer of Bladder (ProCaB) Trial by the Cancer of the Bladder Leuven (CaBLe) Consortium
od: Murat Akand, i dr.
Izdano: (2024-12-01)

A multicentre NCRI phase II study of hypofractionated conformal radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer
od: Choudhury, A, i dr.
Izdano: (2010)

The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.
od: Teo, M, i dr.
Izdano: (2012)

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression
od: Groselj, B, i dr.
Izdano: (2013)

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
od: Groselj, B, i dr.
Izdano: (2013)

Application of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk.
od: Evangelina López de Maturana, i dr.
Izdano: (2013-01-01)

MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.
od: Choudhury, A, i dr.
Izdano: (2010)

The National Institute for Health and Care Excellence (NICE) guidance on bladder cancer; a step in the right direction?
od: Trainor, S, i dr.
Izdano: (2017)

Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.
od: Wu, X, i dr.
Izdano: (2009)

Bladder Cancer
od: A. Karim Kader
Izdano: (2011-01-01)

Identification of methylated genes associated with aggressive bladder cancer.
od: Carmen J Marsit, i dr.
Izdano: (2010-08-01)